Skip to search formSkip to main contentSkip to account menu

15 ML natalizumab 20 MG/ML Injection [Tysabri]

Known as: 15 ML Tysabri 20 MG/ML Injection, natalizumab 300 mg in 15 mL INTRAVENOUS INJECTION [TYSABRI], Tysabri 300 MG per 15 ML Injection 
National Institutes of Health

Related topics

Related topics

7 relations
InjectionPolysorbate 80Sodium ChlorideTysabri

Broader (1)

natalizumab Injection [Tysabri]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study
Multiple sclerosis progressively impairs patients’ ability to independently perform activities of daily living, reduces working… 
2018
2018
Verlaufsuntersuchung von Patienten mit multipler Sklerose unter einer Behandlung mit Natalizumab (Tysabri®) unter besonderer Berücksichtigung der Kernspintomographie
2016
2016
The Societal Impact Of Natalizumab Treatment In The Italian Relapsing-Remitting Multiple Sclerosis Clinical Practice: The Tysabri® Pharmacoeconomics (Type) Study
Review
2015
Review
2015
Spanish consensus on the use of natalizumab (Tysabri®)-2013.
2014
2014
Psychose bei hochaktivem MS-Verlauf
ZusammenfassungDas therapeutische Angebot im Bereich der multiplen Sklerose (MS) hat sich in den letzten Jahren erheblich… 
Review
2013
Review
2013
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis
Natalizumab (Tysabri®) is a humanized monoclonal antibody against the α4 chain of integrins and was the first targeted therapy to… 
2013
2013
LEMP sous Tysabri ® : un gradient nord/sud ?
2011
2011
Risikostratifizierung einer progressiven multifokalen Leukenzephalopathie unter Natalizumab
ZusammenfassungDie JC-Virus (JCV)-assoziierte progressive multifokale Leukenzephalopathie (PML) ist eine schwerwiegende unerw… 
Review
2007
Review
2007
Multiple-Sklerose-Update zur Pathophysiologie und neuen immuntherapeutischen Ansätzen
ZusammenfassungDie Multiple Sklerose (MS) ist eine chronische Erkrankung, die überwiegend junge Erwachsene betrifft und zu… 
2007
2007
Immunosuppression par anticorps monoclonaux dans la sclérose en plaques
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)